MeSH term
Frequency | Condition_Probility | English Abstract | 6 | 0.0 |
Humans | 52 | 0.0 |
Multigene Family | 2 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Tumor Markers, Biological | 2 | 0.0 |
Vimentin/genetics | 4 | 40.0 |
Aged | 11 | 0.0 |
Electromyography | 2 | 1.0 |
Female | 24 | 0.0 |
Male | 16 | 0.0 |
Middle Aged | 16 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Tomography, Emission-Computed | 2 | 1.0 |
Animals | 15 | 0.0 |
Terminology | 2 | 1.0 |
Adult | 13 | 0.0 |
Reference Values | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
*In Situ Hybridization, Fluorescence | 2 | 1.0 |
Swine/*genetics | 3 | 2.0 |
Vimentin/*genetics | 4 | 33.0 |
Diagnosis, Differential | 3 | 0.0 |
Immunohistochemistry | 12 | 0.0 |
Vimentin/biosynthesis | 2 | 14.0 |
Hematopoietic Stem Cell Transplantation | 2 | 1.0 |
Prognosis | 7 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
DNA Primers | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Electrophysiology/methods | 2 | 13.0 |
Cattle | 2 | 0.0 |
*Chromosomes, Human, Pair 10 | 2 | 1.0 |
Immunoenzyme Techniques | 6 | 0.0 |
Adolescent | 2 | 0.0 |
Glial Fibrillary Acidic Protein/analysis | 3 | 1.0 |
Vimentin/analysis | 6 | 2.0 |
Mice | 5 | 0.0 |
Mice, Nude | 2 | 0.0 |
Neoplasm Invasiveness | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Vimentin/*metabolism | 2 | 13.0 |
Hela Cells | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Antigens, Neoplasm/analysis | 2 | 0.0 |
Carcinoembryonic Antigen/analysis | 3 | 2.0 |
Keratin/analysis | 4 | 1.0 |
S100 Proteins/analysis | 2 | 1.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Intermediate Filaments/*pathology | 2 | 66.0 |
CA-15-3 Antigen | 2 | 2.0 |
Child | 2 | 0.0 |
Membrane Glycoproteins/analysis | 2 | 0.0 |
Antibodies, Monoclonal/*diagnostic use | 2 | 0.0 |
Vimentin/*analysis | 2 | 16.0 |
